Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
This study is testing an integrated approach to help low-income homebound seniors who experience depression and are at risk of falls. It combines "Behavioral Activation" (a therapy that helps you engage in more positive activities) with "Fall Prevention" strategies. Researchers want to see if this combined approach, delivered by telephone and in-home visits from coaches, is more effective than either treatment alone or a control group. You might be able to join if you are 50-100 years old, speak English or Spanish, have certain levels of depression and fall risk, and are not currently receiving other similar treatments. The study aims to improve depression symptoms, reduce falls and injuries, and improve your overall quality of life over 36 weeks. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 320 participants. It uses a 4-arm design, meaning participants will be randomly assigned to one of four groups before giving consent.
- What's involved
- Participants in one arm will receive 5 Tele-Behavioral Activation sessions and 4 in-home Fall Prevention sessions. Another arm will receive 9 weekly telephone support calls, each lasting 30 minutes.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your depression symptoms, fall count, injury, and quality of life will be measured at 12, 24, and 36 weeks after you start the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
At a glance
Conditions
NCT05011864
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Texas at Austin
Austin, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Namkee G Choi · PRINCIPAL_INVESTIGATOR · University of Texas at Austin
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Changes from baseline depressive symptom at 12, 24, and 36 weeksat 12, 24, and 36 weeks after baseline
24-item Hamilton Rating Scale for Depression score (score range: 15-40; decreased score since baseline is a positive outcome)
- Changes from baseline fall count and injury at 12, 24, and 36 weeksmonthly (form 12 weeks to 36 weeks)
Changes in six monthly falls calendar data (reduced number of falls since baseline is a positive outcome)
- Changes from baseline EuroQol-5D score at 12, 24, and 36 weeksat 12, 24, and 36 weeks after baseline
Cost-effectiveness measure (score range: 0-20; decreased score since baseline is a positive outcome)
- Changes from baseline physical and mental health service useat 12, 24, and 36 weeks after baseline
Changes in Cornell Services index data (decreased ED visits and hospitalization since baseline is a positive outcome)
- Changes from baseline disability score at 12, 24, and 36 weeksat 12, 24, and 36 weeks after baseline
Changes in 12-item World Health Organization Disability Assessment Schedule score (score range: 0-46; decreased score since baseline is a positive outcome)
- Changes from baseline social engagement and activities score at 12, 24, and 36 weeksat 12, 24, and 36 weeks after baseline
Changes in 10-item Social Engagement and Activities Questionnaire score (score range: 0-50; increased score since baseline is a positive outcome)
- Changes from baseline satisfaction with social roles & activities at 12, 24, and 36 weeksat 12, 24, and 36 weeks after baseline
C (score range: 0-32; increased score since baseline is a positive outcome)